Waterdrop Earnings Call: Fast Growth, Rising Costs

Waterdrop, Inc. ADR Class A ((WDH)) has held its Q4 earnings call. Read on for the main highlights of the call.

Waterdrop, Inc. ADR Class A’s latest earnings call conveyed a broadly upbeat tone, underscored by rapid revenue expansion, resilient profitability, and visible progress in AI and healthcare platforms. Management balanced this optimism with candid acknowledgment of surging costs and some reporting inconsistencies, but the message to investors was clear: growth and innovation remain the priority.

Full-Year Revenue Momentum

Fiscal year 2025 revenue climbed to RMB 3.98 billion, advancing 43.5% year over year and signaling solid demand across Waterdrop’s core businesses. Management framed this performance as evidence that earlier strategic shifts toward higher-quality insurance and healthcare services are now translating into durable top-line scale.

Fourth-Quarter Revenue Acceleration

Fourth-quarter revenue surged to RMB 1.41 billion, up 105.5% from the prior-year period and marking a notable acceleration into year-end. This step-up suggests the company is exiting the year with strong operational momentum rather than simply benefiting from easy comparisons.

Insurance Segment Outperformance

Insurance revenue reached about RMB 3.58 billion for the year, growing 51.3% year over year and remaining the key earnings engine for the group. In Q4, insurance-related income jumped 125% to roughly RMB 1.31 billion, and management cited an operating margin near 18%, underscoring improving scale and product mix.

Consistent Profitability And Net Income Growth

The company has now delivered 16 consecutive quarters of GAAP profitability, highlighting a disciplined approach even during rapid expansion. Fourth-quarter net profit attributable to ordinary shareholders was RMB 153 million, up 62.7% year over year, while full-year net profit reached about RMB 570 million despite heavier investment.

Capital Returns And Shareholder Confidence

Waterdrop’s board approved a cash dividend of CNY 0.03 per ADS, amounting to roughly $10.8 million and signaling confidence in cash generation. Alongside the dividend, the company has repurchased 60.7 million ADS for about $118 million, reinforcing a shareholder-friendly capital allocation stance and underscoring balance sheet strength.

AI Integration And Technology Edge

Management highlighted 72 patent applications related to large language models and broad AI integration across acquisition, customer service, quality control, and R&D workflows. An AI-powered mini-program drove a 33% sequential premium increase, while AI medical expert systems delivered strong sequential gains, as the company pushes toward becoming an AI-native insurance and healthcare platform.

Healthcare Platform Scale And Product Innovation

Waterdrop’s medical platform served 3.68 million patients, and its digital team enrolled more than 4,000 patients over the year, reflecting rising healthcare engagement. The business onboarded 224 pharmaceutical companies and launched 131 new programs in the latest quarter, supported by a patented patient-matching engine that can cut manual screening to just about two minutes.

Growth In Digital Clinical Trials And Services

Digital clinical trial-related revenue recorded roughly 30% growth in the quarter, confirming traction in this emerging healthcare vertical. Medical performance services generated around RMB 260 million in revenue for the year, adding a growing and diversified income stream beyond the core insurance franchise.

ESG Progress And External Recognition

The company expanded its ESG footprint by partnering with 19 organizations to introduce more than 15,500 products focused on sustainability and carbon reduction. These initiatives contributed to an upgraded ESG rating of A+, offering non-financial validation that may appeal to long-term and responsible investors.

Operating Costs Surge With Expansion

Operating costs for the quarter climbed to RMB 680 million, up 109.2% year over year, with total operating costs and expenses hitting RMB 1.33 billion, also up 109.4%. On a full-year basis, operating costs and expenses increased 39.1%, flagging mounting margin pressure as the company invests aggressively to sustain growth.

Rising Selling And Marketing Spend

Selling and marketing expenses shot up to roughly RMB 510 million, a 178.4% year-over-year jump driven by heavier use of third-party traffic channels and active scaling of customer acquisition. Management framed this as front-loaded investment intended to secure market share and feed the pipeline for future premium growth.

Higher Referral And Service Fees

Referral and service fees increased by about RMB 320 million in the period, adding significantly to the overall rise in operating costs. The higher variable cost per unit of revenue highlights a more expensive growth path near term, though management suggested AI and process optimization may improve efficiency over time.

Profit Reporting Inconsistencies

Investors were left with some uncertainty as the company reported conflicting growth rates for full-year net profit attributable to ordinary shareholders, citing both 54.8% and 4.8% year-over-year increases on the same RMB 570 million base. This discrepancy clouds direct comparability and suggests shareholders should watch future disclosures closely for improved clarity.

Margin Pressure From Rapid Expense Growth

While revenue and insurance income are growing quickly, quarterly expense growth outpaced top-line expansion, particularly in selling, marketing, and referral fees. Management acknowledged that this imbalance may weigh on near-term margins until scale, AI-enabled efficiencies, and better unit economics catch up with the investment cycle.

Forward-Looking Guidance And Strategic Direction

For 2026, management is targeting double-digit growth in both revenue and profit, while only modestly increasing marketing and AI spending versus the 2025 base of RMB 3.98 billion in revenue and RMB 570 million net profit. The company reiterated its commitment to remain GAAP-profitable, continue capital returns through dividends and completed buybacks, and deepen its AI capabilities as a core competitive advantage.

Waterdrop’s earnings call painted the picture of a company in high-growth mode, using AI and healthcare innovation to fuel strong top-line gains while returning capital to shareholders. Investors will need to weigh the impressive revenue trajectory and technology edge against rapid cost escalation and disclosure inconsistencies, but the underlying momentum and strategic clarity remain compelling for growth-oriented holders.